Tag Archives: FDA

Cellceutix Corp (OTCMKTS:CTIX) has been subject to some pretty harsh criticism as late, and is currently at the center of a legal dispute between it and an anonymous SA blogger called Mako Research surrounding a report it put out that seemingly...

Viaderma Inc (OTCMKTS:VDRM) is an early runner in the micro cap space this week. The company is up close to 35% on its weekly open, and looks set to register further gains as action matures throughout the session on Tuesday. What is driving...

At the beginning of February, we took a look at development stage biotech company Pulmatrix Inc (NASDAQ:PULM) as part of this piece.  At the time, the company had just run up to the tune of 130% on the back of an expedited approval process...

Our regular readers will be more than aware by now that Peregrine Pharmaceuticals (NASDAQ:PPHM) is a company we keep on coming back to. The reason we keep on coming back to it is that we are trying to get the point across that – at its current...

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) ran up towards the end of last week on basically no news, and is running again early session in the US on Monday. March to date, the company is up more than 75%. This company is gaining speculative...

Innovus Pharmaceuticals Inc (OTCMKTS:INNV) is a name that continues to fly under the radar of most investors. The company has grown revenues from just $700,000 in 2015 to $4.8 million last year and is on track to do $15 million this year, even...

Ocera Therapeutics Inc (NASDAQ:OCRX) is up more than 200% this week, and currently trades for just shy of $2 a share. Those familiar with this one will know that the company basically collapsed back at the end of January, when it put out data...

Kura Oncology Inc (NASDAQ:KURA) is a big biotech runner this week, with the company gaining more than 30% during the Tuesday session, and looking set to pick up further strength on Wednesday on the back of a few percentage point run premarket....

Back during the middle of February, we took a look at Bellerophon Therapeutics Inc (NASDAQ:BLPH) as part of this coverage. At the time, the company was trading at around $1.3 a share. The driver behind our coverage was a run that came seemingly...

Our more regular readers will know that Peregrine Pharmaceuticals (NASDAQ:PPHM) is one of the stocks we visit regularly. The company – as we have stated in the past, and an opinion that still stands – is one of the most mis-valued/misunderstood...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter